Wellgistics Health, Inc. functions as a primary wholesaler and distributor of pharmaceutical products throughout the United States, catering to both drug manufacturers ...
Wellgistics Health, Inc. (NASDAQ: WGRX) is a healthcare-focused company positioned at the intersection of pharmaceutical distribution and health-technology enablement. The company is described as operating as a primary wholesaler and distributor of pharmaceutical products across the United States, serving both drug manufacturers and independent retail pharmacies. Its catalog includes generic ...Wellgistics Health, Inc. (NASDAQ: WGRX) is a healthcare-focused company positioned at the intersection of pharmaceutical distribution and health-technology enablement. The company is described as operating as a primary wholesaler and distributor of pharmaceutical products across the United States, serving both drug manufacturers and independent retail pharmacies. Its catalog includes generic and brand-name pharmaceuticals as well as over-the-counter healthcare and consumer merchandise—typical of a distributor model that requires fulfillment, inventory management, and reliable supply-chain execution.
Beyond distribution, Wellgistics also provides third-party logistics (3PL) services tailored to small-to-mid-sized pharmaceutical producers. These services include warehousing, inventory control, pick-and-pack operations, and shipping solutions. The operational premise is that mid-market and emerging pharmaceutical manufacturers often need specialized logistics support to scale distribution without building their own extensive infrastructure. By offering logistics and fulfillment capabilities, Wellgistics can capture value not only from product flow but also from operational services that reduce friction for its customers.
A notable part of the business is its technology and pharmacy-network enablement. The company operates the DelivMeds platform, which is positioned as an integrated pharmaceutical hub designed to streamline prescription transfers while providing backend clinical concierge support to independent pharmacies. This reflects a patient-centric approach that aims to improve continuity of care during prescription transfer processes—an area that can be operationally complex for independent pharmacies.
From a corporate development perspective, the company was founded in 2022 and later adopted its current name “Wellgistics Health, Inc.” in October 2024 (previously operating as Danam Health, Inc., per the dataset description). The company’s public-market profile in the provided data shows a small market capitalization and trading on the NASDAQ Capital Market.
Financially, the dataset snapshot indicates weak profitability and negative margins on key measures (e.g., negative net/profit margins and negative returns), which is consistent with an operating model that may involve growth investments, platform development, and scaling of logistics and distribution infrastructure. Liquidity ratios shown in the snapshot (e.g., current ratio) are also low, suggesting the company may rely on working-capital management and funding flexibility as it scales.
Key people referenced in the provided materials include Prashant Patel, noted in management/board-related announcements as President and Interim-CEO (and a board member). Company positioning and stated priorities in the referenced materials also point to ongoing technology and transaction-related initiatives connected to DelivMeds.
Overall, Wellgistics Health’s “wishes” or strategic intent, based on the description and references, appear to center on expanding pharmacy-network adoption, strengthening distribution and 3PL capabilities, and leveraging health-tech platforms to improve prescription-transfer workflows and patient outcomes while scaling the business under the Wellgistics ecosystem.
YoYYoY means Year-over-Year. It compares the latest annual value with the previous annual value to show long-term trend strength.
QoQQoQ means Quarter-over-Quarter. It compares the latest quarter with the immediately previous quarter to show short-term momentum changes.
RevenueThe total money that came through the front door from selling things, before paying a single bill. Think of it as the grand total of every credit card swipe from customers. (YoY compares this year to last year's performance, while QoQ compares the current three months to the previous three).
$23.3M
+28.7%
+14.1%
Net IncomeThe absolute bottom line. If the company paid every single supplier, employee, banker, and tax collector, this is the actual money left in their pocket at the end of the day.
$-101.3M
-1377.1%
-137.2%
Gross MarginThe basic markup. If they sell a $100 pair of sneakers, this percentage tells you how much of that price tag is profit right after paying for the rubber and shoelaces, but before paying for things like store rent or TV commercials.
-41.3%
-523.6%
+185.6%
Operating MarginThe 'day job' efficiency score. Out of every dollar a customer spends, this shows how many cents the company keeps after making the product AND paying for all the everyday corporate overhead (like salaries, marketing, and keeping the lights on).
-347.9%
-926.4%
-7.0%
Net MarginThe final take-home percentage. When you strip away every conceivable cost, tax, and interest payment, this is the exact number of cents the company truly gets to keep from every dollar in sales.
-433.9%
-1047.4%
-107.8%
Free Cash FlowThe holy grail of corporate cash. It's the spendable, physical money left over after the business pays for its daily operations AND buys the big, expensive upgrades (like new factories or servers) it needs to survive. This is the 'free' money they can use to pay dividends or buy back stock.
$-10.9M
-577.5%
+25.7%
FCF MarginThe ultimate cash conversion rate. It shows how good the company is at turning regular sales directly into cold, hard, spendable cash. A high percentage means the business is an absolute cash-printing machine.
-46.5%
-426.3%
+34.9%
Debt / EquityThe financial risk gauge. It compares how much of the company's empire was built using borrowed money (loans) versus the owners' own money (shareholders). A high number means they are heavily leveraged and playing a riskier game; a low number means they are playing it safe.
-199.0%
-153.4%
+12.9%
Current RatioThe 12-month survival check. It simply compares the cash they have right now (plus things they can quickly turn into cash) against the immediate bills they absolutely must pay this year. A score above 1 means they have enough in the wallet to cover the upcoming bills without panicking.
0.09x
-76.3%
+66.6%
Total AssetsThe absolute size of the company's empire. It bundles together absolutely everything of value they own—from the cash in the register and the inventory in the warehouse, to the software patents in the vault and the factories on the ground.
